Composants NBI
Les constituants NASDAQ Biotechnology sont disponibles dans le tableau ci-dessous. Triez les composants de l'action NBI selon diverses mesures et données financières telles que la performance, les dividendes, le compte de résultat et le bilan.
Symbole | Capitalisation boursière | Prix | Variation % | Volume | Volume Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Secteur | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AZNAstraZeneca PLCDR | 236,4 B USD | 74,24 USD | −2,30% | 6,11 M | 0,82 | 32,94 | 2,25 USD | +18,08% | 2,00% | Technologie de la santé | Strong Buy |
 AMGNAmgen Inc. | 171,31 B USD | 318,89 USD | −2,59% | 3,08 M | 0,90 | 42,26 | 7,55 USD | −39,56% | 2,79% | Technologie de la santé | Buy |
 SNYSanofiDR | 148,84 B USD | 58,74 USD | −1,03% | 1,89 M | 0,58 | 24,53 | 2,39 USD | +3,07% | 2,49% | Technologie de la santé | Buy |
 GILDGilead Sciences, Inc. | 142,5 B USD | 114,43 USD | −2,37% | 11,48 M | 1,10 | 311,71 | 0,37 USD | −91,85% | 2,63% | Technologie de la santé | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 125,4 B USD | 488,34 USD | −2,33% | 1,39 M | 1,03 | — | −2,20 USD | −115,85% | 0,00% | Technologie de la santé | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 78,51 B USD | 718,16 USD | −3,58% | 1,11 M | 1,14 | 18,76 | 38,29 USD | +10,17% | 0,12% | Technologie de la santé | Buy |
 ARGXargenx SEDR | 34,97 B USD | 580,43 USD | +1,65% | 408 K | 1,21 | 45,50 | 12,76 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 30,91 B USD | 238,74 USD | +2,43% | 603,11 K | 0,76 | — | −2,17 USD | +39,03% | 0,00% | Technologie de la santé | Buy |
 ONCBeiGene, Ltd.DR | 27,07 B USD | 245,71 USD | +1,26% | 375,68 K | 0,48 | — | −6,13 USD | +27,88% | 0,00% | Technologie de la santé | Strong Buy |
 BNTXBioNTech SEDR | 25,26 B USD | 98,39 USD | −6,61% | 1,01 M | 1,09 | — | −2,15 USD | −118,72% | 0,00% | Technologie de la santé | Buy |
 BIIBBiogen Inc. | 21,03 B USD | 143,66 USD | −4,68% | 1,86 M | 0,99 | 12,85 | 11,18 USD | +40,10% | 0,00% | Technologie de la santé | Buy |
 RPRXRoyalty Pharma plc | 18,71 B USD | 32,46 USD | −0,89% | 4,37 M | 1,03 | 16,93 | 1,92 USD | −24,37% | 2,60% | Technologie de la santé | Strong Buy |
 GMABGenmab A/SDR | 14,02 B USD | 20,26 USD | −7,80% | 3,93 M | 2,87 | 11,57 | 1,75 USD | +82,11% | 0,00% | Technologie de la santé | Buy |
 ITCIIntra-Cellular Therapies Inc. | 13,95 B USD | 131,24 USD | −0,01% | 3,74 M | 1,57 | — | −0,72 USD | +50,50% | 0,00% | Technologie de la santé | Neutre |
 UTHRUnited Therapeutics Corporation | 13,67 B USD | 304,42 USD | −4,23% | 553,5 K | 0,76 | 12,38 | 24,60 USD | +24,00% | 0,00% | Technologie de la santé | Buy |
 SMMTSummit Therapeutics Inc. | 13,65 B USD | 18,50 USD | +2,83% | 2,83 M | 1,02 | — | −0,31 USD | +80,00% | 0,00% | Technologie de la santé | Strong Buy |
 BMRNBioMarin Pharmaceutical Inc. | 13,45 B USD | 70,49 USD | −2,14% | 1,22 M | 0,80 | 32,05 | 2,20 USD | +152,46% | 0,00% | Technologie de la santé | Buy |
 ILMNIllumina, Inc. | 13,39 B USD | 84,52 USD | −1,69% | 3,72 M | 1,32 | — | −7,72 USD | −5,17% | 0,00% | Technologie de la santé | Buy |
 INSMInsmed Incorporated | 13,34 B USD | 73,70 USD | +0,86% | 2,02 M | 0,94 | — | −5,59 USD | −4,45% | 0,00% | Technologie de la santé | Strong Buy |
 INCYIncyte Corporation | 13,17 B USD | 68,07 USD | −4,30% | 1,63 M | 0,99 | 251,00 | 0,27 USD | −89,75% | 0,00% | Technologie de la santé | Buy |
 MRNAModerna, Inc. | 13,03 B USD | 33,76 USD | −6,12% | 12,41 M | 1,08 | — | −9,28 USD | +25,17% | 0,00% | Technologie de la santé | Neutre |
 VTRSViatris Inc. | 11,15 B USD | 9,34 USD | −1,68% | 15,59 M | 0,72 | — | −0,53 USD | −1 358,49% | 5,05% | Technologie de la santé | Neutre |
 NBIXNeurocrine Biosciences, Inc. | 10,69 B USD | 107,22 USD | −3,29% | 1,94 M | 1,43 | 32,58 | 3,29 USD | +35,43% | 0,00% | Technologie de la santé | Buy |
 EXELExelixis, Inc. | 10,34 B USD | 36,93 USD | −5,68% | 3,28 M | 1,19 | 20,83 | 1,77 USD | +173,87% | 0,00% | Technologie de la santé | Buy |
 MEDPMedpace Holdings, Inc. | 9,93 B USD | 325,87 USD | −3,42% | 441,2 K | 1,05 | 25,79 | 12,63 USD | +42,34% | 0,00% | Services Commerciaux | Buy |
 SRPTSarepta Therapeutics, Inc. | 9,77 B USD | 100,71 USD | +1,02% | 1,02 M | 0,77 | 42,25 | 2,38 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 PCVXVaxcyte, Inc. | 8,99 B USD | 69,85 USD | +1,39% | 973,2 K | 0,63 | — | −3,88 USD | +7,75% | 0,00% | Technologie de la santé | Strong Buy |
 JAZZJazz Pharmaceuticals plc | 8,31 B USD | 136,86 USD | −0,43% | 910,37 K | 0,70 | 15,64 | 8,75 USD | +51,57% | 0,00% | Technologie de la santé | Strong Buy |
 ASNDAscendis Pharma A/SDR | 8,27 B USD | 145,63 USD | +5,39% | 397,03 K | 0,85 | — | −7,13 USD | +22,96% | 0,00% | Technologie de la santé | Strong Buy |
 TEMTempus AI, Inc. | 7,85 B USD | 45,58 USD | +0,91% | 8,91 M | 0,62 | — | −4,75 USD | −195,58% | 0,00% | Services technologiques | Buy |
 HALOHalozyme Therapeutics, Inc. | 7,57 B USD | 61,45 USD | +0,02% | 1,22 M | 0,85 | 17,90 | 3,43 USD | +62,77% | 0,00% | Technologie de la santé | Buy |
 ROIVRoivant Sciences Ltd. | 7,53 B USD | 10,55 USD | −0,28% | 6,88 M | 1,30 | — | −0,14 USD | −102,78% | 0,00% | Technologie de la santé | Strong Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 7,41 B USD | 335,39 USD | +1,89% | 528,29 K | 1,01 | — | −22,11 USD | −10,89% | 0,00% | Technologie de la santé | Strong Buy |
 RVMDRevolution Medicines, Inc. | 7,23 B USD | 38,89 USD | +5,62% | 1,98 M | 1,19 | — | −3,57 USD | +5,49% | 0,00% | Technologie de la santé | Strong Buy |
 GRFSGrifols, S.A.DR | 6,66 B USD | 7,73 USD | −0,90% | 1,3 M | 0,69 | — | — | — | 0,00% | Technologie de la santé | Neutre |
 LEGNLegend Biotech CorporationDR | 6,24 B USD | 37,19 USD | +9,29% | 1,73 M | 1,27 | — | −1,91 USD | +35,99% | 0,00% | Technologie de la santé | Strong Buy |
 BBIOBridgeBio Pharma, Inc. | 6,15 B USD | 32,34 USD | +2,99% | 3,34 M | 0,77 | — | −2,85 USD | +27,90% | 0,00% | Technologie de la santé | Strong Buy |
 AXSMAxsome Therapeutics, Inc. | 5,83 B USD | 119,50 USD | +0,61% | 824,91 K | 1,14 | — | −6,00 USD | −15,29% | 0,00% | Technologie de la santé | Strong Buy |
 BPMCBlueprint Medicines Corporation | 5,61 B USD | 87,76 USD | +1,23% | 618,42 K | 0,65 | — | −1,07 USD | +87,20% | 0,00% | Technologie de la santé | Buy |
 ALKSAlkermes plc | 5,57 B USD | 34,26 USD | −2,78% | 2,71 M | 1,64 | 15,72 | 2,18 USD | +5,35% | 0,00% | Technologie de la santé | Buy |
 KRYSKrystal Biotech, Inc. | 5,33 B USD | 184,88 USD | +0,61% | 344,83 K | 1,19 | 61,87 | 2,99 USD | +3 261,08% | 0,00% | Technologie de la santé | Strong Buy |
 GHGuardant Health, Inc. | 5,26 B USD | 42,63 USD | +18,95% | 4,24 M | 1,85 | — | −3,56 USD | +16,91% | 0,00% | Services de santé | Strong Buy |
 CYTKCytokinetics, Incorporated | 5,26 B USD | 44,40 USD | +2,52% | 1,97 M | 1,27 | — | −5,28 USD | +3,20% | 0,00% | Technologie de la santé | Strong Buy |
 IONSIonis Pharmaceuticals, Inc. | 5,25 B USD | 33,03 USD | +2,51% | 1,93 M | 1,17 | — | −3,04 USD | −18,79% | 0,00% | Technologie de la santé | Buy |
 VRNAVerona Pharma plcDR | 5,19 B USD | 62,70 USD | +2,20% | 1,16 M | 0,73 | — | −2,16 USD | −213,94% | 0,00% | Technologie de la santé | Strong Buy |
 NUVLNuvalent, Inc. | 5,03 B USD | 70,25 USD | +4,26% | 1,07 M | 1,95 | — | −3,91 USD | −81,09% | 0,00% | Technologie de la santé | Strong Buy |
 PTCTPTC Therapeutics, Inc. | 4,15 B USD | 52,59 USD | +0,19% | 860,72 K | 0,85 | — | −4,73 USD | +43,51% | 0,00% | Technologie de la santé | Buy |
 ADMAADMA Biologics Inc | 4,1 B USD | 17,35 USD | +4,46% | 2,55 M | 0,78 | 21,30 | 0,81 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 ZLABZai Lab LimitedDR | 3,93 B USD | 35,35 USD | +1,90% | 429,91 K | 0,29 | — | −2,60 USD | +24,92% | 0,00% | Technologie de la santé | Strong Buy |
 SWTXSpringWorks Therapeutics, Inc. | 3,81 B USD | 50,89 USD | +5,06% | 2,28 M | 0,83 | — | −3,48 USD | +30,06% | 0,00% | Technologie de la santé | Strong Buy |
 ACLXArcellx, Inc. | 3,76 B USD | 68,36 USD | −5,21% | 752,1 K | 1,02 | — | −1,99 USD | −31,69% | 0,00% | Technologie de la santé | Strong Buy |
 PTGXProtagonist Therapeutics, Inc. | 3,67 B USD | 59,76 USD | +6,81% | 2,62 M | 1,48 | 14,21 | 4,21 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 CRSPCRISPR Therapeutics AG | 3,63 B USD | 42,37 USD | −2,24% | 1,98 M | 1,12 | — | −4,36 USD | −121,15% | 0,00% | Technologie de la santé | Buy |
 RNAAvidity Biosciences, Inc. | 3,56 B USD | 29,58 USD | −1,53% | 1,01 M | 0,75 | — | −2,90 USD | +0,17% | 0,00% | Technologie de la santé | Strong Buy |
 RAREUltragenyx Pharmaceutical Inc. | 3,55 B USD | 38,33 USD | +2,21% | 840,5 K | 0,94 | — | −6,34 USD | +23,93% | 0,00% | Technologie de la santé | Strong Buy |
 AKROAkero Therapeutics, Inc. | 3,49 B USD | 43,82 USD | +5,13% | 1,35 M | 1,45 | — | −3,75 USD | −31,37% | 0,00% | Technologie de la santé | Strong Buy |
 IMVTImmunovant, Inc. | 3,33 B USD | 19,61 USD | −3,40% | 948,23 K | 0,90 | — | −2,62 USD | −43,10% | 0,00% | Technologie de la santé | Strong Buy |
 MRUSMerus N.V. | 3,29 B USD | 47,58 USD | +1,78% | 732,06 K | 0,94 | — | −3,32 USD | −10,95% | 0,00% | Technologie de la santé | Strong Buy |
 SRRKScholar Rock Holding Corporation | 3,27 B USD | 34,50 USD | −1,85% | 676,51 K | 0,74 | — | −2,57 USD | −22,34% | 0,00% | Technologie de la santé | Strong Buy |
 ALVOAlvotech | 3,26 B USD | 10,81 USD | +1,03% | 173,38 K | 1,51 | — | −1,66 USD | +28,65% | 0,00% | Technologie de la santé | Buy |
 APLSApellis Pharmaceuticals, Inc. | 3,2 B USD | 25,52 USD | +1,51% | 1,4 M | 0,77 | — | −1,60 USD | +64,32% | 0,00% | Technologie de la santé | Buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 3,19 B USD | 34,26 USD | +1,51% | 1 M | 0,83 | — | −3,70 USD | −0,12% | 0,00% | Technologie de la santé | Strong Buy |
 RYTMRhythm Pharmaceuticals, Inc. | 3,16 B USD | 50,06 USD | +3,09% | 1,01 M | 1,57 | — | −4,36 USD | −35,93% | 0,00% | Technologie de la santé | Strong Buy |
 ACADACADIA Pharmaceuticals Inc. | 2,87 B USD | 17,19 USD | 0,00% | 1,56 M | 0,88 | 12,64 | 1,36 USD | — | 0,00% | Technologie de la santé | Buy |
 HCMHUTCHMED (China) LimitedDR | 2,78 B USD | 15,68 USD | +1,62% | 148,96 K | 1,80 | — | −0,25 USD | −16,10% | 0,00% | Technologie de la santé | Strong Buy |
 AMRXAmneal Pharmaceuticals, Inc. | 2,74 B USD | 8,84 USD | +1,61% | 1,04 M | 0,47 | — | −0,38 USD | −21,58% | 0,00% | Technologie de la santé | Strong Buy |
 FOLDAmicus Therapeutics, Inc. | 2,73 B USD | 8,88 USD | +2,90% | 3,63 M | 1,54 | — | −0,18 USD | +64,39% | 0,00% | Technologie de la santé | Buy |
 XENEXenon Pharmaceuticals Inc. | 2,66 B USD | 34,76 USD | +1,44% | 666,46 K | 1,10 | — | −3,01 USD | −10,19% | 0,00% | Technologie de la santé | Strong Buy |
 EWTXEdgewise Therapeutics, Inc. | 2,61 B USD | 27,40 USD | −0,47% | 1,51 M | 1,14 | — | −1,45 USD | +7,97% | 0,00% | Technologie de la santé | Strong Buy |
 NAMSNewAmsterdam Pharma Company N.V. | 2,51 B USD | 22,88 USD | −2,10% | 1,82 M | 1,31 | — | −2,60 USD | −1 203,87% | 0,00% | Technologie de la santé | Strong Buy |
 RXRXRecursion Pharmaceuticals, Inc. | 2,44 B USD | 6,06 USD | −1,14% | 18,75 M | 0,74 | — | −1,66 USD | −6,86% | 0,00% | Technologie de la santé | Buy |
 VCYTVeracyte, Inc. | 2,42 B USD | 31,10 USD | +2,37% | 1,29 M | 0,87 | 101,47 | 0,31 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 IBRXImmunityBio, Inc. | 2,41 B USD | 2,82 USD | −3,09% | 5,16 M | 0,79 | — | −0,63 USD | +43,89% | 0,00% | Technologie de la santé | Strong Buy |
 APGEApogee Therapeutics, Inc. | 2,4 B USD | 40,27 USD | +7,27% | 988,54 K | 1,23 | — | −3,23 USD | −94,92% | 0,00% | Technologie de la santé | Strong Buy |
 VCELVericel Corporation | 2,39 B USD | 47,81 USD | −2,13% | 343,4 K | 0,64 | 258,99 | 0,18 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 NVCRNovoCure Limited | 2,34 B USD | 21,32 USD | +5,08% | 1,25 M | 0,89 | — | −1,56 USD | +19,76% | 0,00% | Technologie de la santé | Buy |
 TWSTTwist Bioscience Corporation | 2,33 B USD | 39,13 USD | +6,59% | 1,78 M | 1,30 | — | −3,38 USD | +6,06% | 0,00% | Technologie de la santé | Buy |
 BEAMBeam Therapeutics Inc. | 2,21 B USD | 26,42 USD | +2,82% | 3,02 M | 1,34 | — | −4,58 USD | −139,89% | 0,00% | Technologie de la santé | Buy |
 DNLIDenali Therapeutics Inc. | 2,18 B USD | 15,04 USD | +0,60% | 1,75 M | 1,08 | — | −2,58 USD | −136,50% | 0,00% | Technologie de la santé | Strong Buy |
 KYMRKymera Therapeutics, Inc. | 2,16 B USD | 33,27 USD | +0,76% | 778,07 K | 0,83 | — | −2,97 USD | −17,79% | 0,00% | Technologie de la santé | Strong Buy |
 MIRMMirum Pharmaceuticals, Inc. | 2,16 B USD | 44,06 USD | +2,44% | 445,18 K | 0,72 | — | −1,85 USD | +53,98% | 0,00% | Technologie de la santé | Strong Buy |
 CNTACentessa Pharmaceuticals plcDR | 2,08 B USD | 16,47 USD | +4,24% | 1,29 M | 1,29 | — | −1,53 USD | +7,72% | 0,00% | Technologie de la santé | Strong Buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 2,07 B USD | 15,06 USD | −0,99% | 2,03 M | 1,33 | — | −5,15 USD | −85,82% | 0,00% | Technologie de la santé | Buy |
 LGNDLigand Pharmaceuticals Incorporated | 2,04 B USD | 105,79 USD | −3,21% | 171,29 K | 1,34 | — | −0,15 USD | −105,31% | 0,00% | Technologie de la santé | Strong Buy |
 CGONCG Oncology, Inc. | 2,02 B USD | 26,30 USD | +0,42% | 669,37 K | 0,94 | — | −1,28 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1,93 B USD | 33,65 USD | −2,27% | 641 K | 0,78 | 13,41 | 2,51 USD | +17,72% | 0,00% | Technologie de la santé | Strong Buy |
 IRONDisc Medicine, Inc. | 1,86 B USD | 53,89 USD | +0,97% | 483,59 K | 1,52 | — | −3,99 USD | −14,19% | 0,00% | Technologie de la santé | Strong Buy |
 AGIOAgios Pharmaceuticals, Inc. | 1,84 B USD | 32,13 USD | +0,44% | 839,7 K | 1,16 | 2,82 | 11,40 USD | — | 0,00% | Technologie de la santé | Buy |
 ARQTArcutis Biotherapeutics, Inc. | 1,84 B USD | 15,49 USD | +7,72% | 2,58 M | 1,02 | — | −1,16 USD | +70,23% | 0,00% | Technologie de la santé | Strong Buy |
 TARSTarsus Pharmaceuticals, Inc. | 1,81 B USD | 47,15 USD | +5,74% | 554,37 K | 0,72 | — | −3,10 USD | +33,12% | 0,00% | Technologie de la santé | Strong Buy |
 VERAVera Therapeutics, Inc. | 1,81 B USD | 28,36 USD | +2,01% | 501,31 K | 0,65 | — | −2,74 USD | −20,03% | 0,00% | Technologie de la santé | Strong Buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1,79 B USD | 32,02 USD | −2,50% | 1,32 M | 1,61 | 24,29 | 1,32 USD | — | 0,00% | Technologie de la santé | Buy |
 JANXJanux Therapeutics, Inc. | 1,73 B USD | 29,25 USD | −3,21% | 938,46 K | 0,90 | — | −1,28 USD | +4,61% | 0,00% | Technologie de la santé | Strong Buy |
 GLPGGalapagos NVDR | 1,72 B USD | 25,63 USD | −0,77% | 211,79 K | 1,05 | 21,41 | 1,20 USD | — | 0,00% | Technologie de la santé | Neutre |
 DVAXDynavax Technologies Corporation | 1,71 B USD | 13,79 USD | −4,17% | 3,46 M | 0,96 | 78,94 | 0,17 USD | — | 0,00% | Technologie de la santé | Buy |
 MESOMesoblast LimitedDR | 1,64 B USD | 13,28 USD | +1,61% | 487,17 K | 1,02 | — | −0,93 USD | +12,87% | 0,00% | Technologie de la santé | Strong Buy |
 IDYAIDEAYA Biosciences, Inc. | 1,62 B USD | 18,51 USD | +5,53% | 956,2 K | 1,11 | — | −3,30 USD | −67,97% | 0,00% | Technologie de la santé | Strong Buy |
 TVTXTravere Therapeutics, Inc. | 1,61 B USD | 18,13 USD | +1,43% | 1,79 M | 1,06 | — | −4,10 USD | +10,01% | 0,00% | Technologie de la santé | Strong Buy |
 WVEWave Life Sciences Ltd. | 1,6 B USD | 10,40 USD | +10,76% | 1,55 M | 1,18 | — | −0,79 USD | −44,06% | 0,00% | Technologie de la santé | Strong Buy |
 MNKDMannKind Corporation | 1,59 B USD | 5,25 USD | +5,21% | 2,39 M | 0,83 | 57,38 | 0,09 USD | — | 0,00% | Technologie de la santé | Strong Buy |